ASHLEY TOULSON: Open Payments
NPI 1194591396 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$245 in 12 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $34 · 2025 $245
Food & beverage: $245
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 5 | $105 |
| ABBVIE INC. | 5 | $88 |
| Alkermes, Inc. | 1 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
Products named: INGREZZA, VRAYLAR, ARISTADA, CAPLYTA.
Industry payments across MD — which companies pay providers there.
